19.02.2025
Registration for our Neurofeedback workshop is now open!
Our third annual CPNN+ hybrid workshop will be held on 19th & 20th June 2025 at the Advanced Research Centre (ARC) at the University of Glasgow. Please visit our 'activities' tab for more details or click into this news article to register below.
To register, please visit https://forms.office.com/e/82FQyyQzzX
Open to all, and aimed at early career researchers, our CPNN+ Neurofeedback workshop will include talks from various guest speakers, two afternoon workshops and dinner on the first evening. Access the ARC website here – https://www.gla.ac.uk/research/arc/
The aims of our workshop will include:
• An interdisciplinary workshop that aims to explore the theoretical and practical aspects of neurofeedback with a focus on its application on pain treatment.
• There will be morning talks across a range of translational topics that will cover neurofeedback in invasive and non invasive experimental human models, methodological considerations and clinical studies. Ethical aspect of using neurotechnology and its placebo effect will also be discussed.
• Afternoon interactive workshops will focus on how to design and implement EEG based neurofeedback and introduction to real time fMRI with a demonstration of its experimental setup.
More news
See all
‘What We Carry’ exhibited at The Corridor Gallery
Our recent chronic pain PPI project, 'What We Carry: Living with Pain' is currently on exhibition at the John Radcliffe Hospital, Oxford, within The Corridor Gallery until 6th December 2025.
PPI Project – ‘What We Carry: Living with Pain’
Amplifying Voices in Pain Research. This powerful project explores chronic pain through photography, writing, and storytelling. The work – created in collaboration with pain sufferers – gives voice to experiences often invisible and misunderstood, offering both a creative outlet and vital insight for researchers and clinicians.
New Oxford-led project aims to revolutionise chronic pain treatment
The University of Oxford is to lead a new six-year, £11 million project backed by the Engineering and Physical Sciences Research Council (EPSRC) which aims develop a new generation of personalised treatments capable of reducing or abolishing chronic pain.